Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Depreciation & Amortization (CF): 2010-2017

Historic Depreciation & Amortization (CF) for Tenax Therapeutics (TENX) over the last 7 years, with Dec 2017 value amounting to $3,022.

  • Tenax Therapeutics' Depreciation & Amortization (CF) fell 31.64% to $3,022 in Q4 2017 from the same period last year, while for Dec 2017 it was $13,621, marking a year-over-year decrease of 28.13%. This contributed to the annual value of $8,000 for FY2023, which is 55.55% up from last year.
  • Per Tenax Therapeutics' latest filing, its Depreciation & Amortization (CF) stood at $3,022 for Q4 2017, which was down 3.85% from $3,143 recorded in Q3 2017.
  • In the past 5 years, Tenax Therapeutics' Depreciation & Amortization (CF) registered a high of $2.3 million during Q1 2014, and its lowest value of $3,022 during Q4 2017.
  • Over the past 3 years, Tenax Therapeutics' median Depreciation & Amortization (CF) value was $4,638 (recorded in 2016), while the average stood at $10,635.
  • In the last 5 years, Tenax Therapeutics' Depreciation & Amortization (CF) spiked by 5,374.71% in 2013 and then crashed by 99.00% in 2014.
  • Quarterly analysis of 5 years shows Tenax Therapeutics' Depreciation & Amortization (CF) stood at $2.3 million in 2013, then slumped by 98.35% to $37,893 in 2014, then tumbled by 67.13% to $12,650 in 2015, then reached $4,421 in 2016, then slumped by 31.64% to $3,022 in 2017.
  • Its last three reported values are $3,022 in Q4 2017, $3,143 for Q3 2017, and $3,424 during Q2 2017.